We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

146 hedge funds and large institutions have $734M invested in Cogent Biosciences in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

70% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 37

56% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $1.13M

34% more capital invested

Capital invested by funds: $547M → $734M (+$187M)

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

1% more funds holding

Funds holding: 144 → 146 (+2)

2.93% less ownership

Funds ownership: 108.08% → 105.14% (-2.9%)

Holders
146
Holders Change
+2
Holders Change %
+1.39%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
33
Increased
63
Reduced
37
Closed
30
Calls
$1.76M
Puts
$1.13M
Net Calls
+$632K
Net Calls Change
-$13K

Top Buyers

1
State Street
State Street
Massachusetts
+$21.5M
2
KCM
Kynam Capital Management
New Jersey
+$16.4M
3
SI
Sofinnova Investments
California
+$14.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M

Top Sellers

1
SCM
Suvretta Capital Management
New York
-$21M
2
Morgan Stanley
Morgan Stanley
New York
-$16.5M
3
EAM
Eventide Asset Management
Massachusetts
-$13.1M
4
FLSM
Frazier Life Sciences Management
California
-$6.54M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
151
ExodusPoint Capital Management
New York
– -$1.05M -179,415 Closed
Schroder Investment Management Group
152
Schroder Investment Management Group
United Kingdom
– -$794K -135,000 Closed
LCM
153
Landscape Capital Management
New Jersey
– -$604K -102,730 Closed
PHP
154
Parkman Healthcare Partners
Connecticut
– -$569K -96,837 Closed
GCP
155
GSA Capital Partners
United Kingdom
– -$565K -96,014 Closed
HF
156
HRT Financial
New York
– -$530K -90,215 Closed
Connor, Clark & Lunn Investment Management (CC&L)
157
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$492K -83,600 Closed
Tudor Investment Corp
158
Tudor Investment Corp
Connecticut
– -$341K -58,031 Closed
SSA
159
Sierra Summit Advisors
Nevada
– -$331K -56,231 Closed
NRD
160
Nebula Research & Development
New York
– -$306K -51,972 Closed
Alyeska Investment Group
161
Alyeska Investment Group
Illinois
– -$294K -50,000 Closed
Marshall Wace
162
Marshall Wace
United Kingdom
– -$291K -49,466 Closed
Capstone Investment Advisors
163
Capstone Investment Advisors
New York
– -$238K -40,501 Closed
PMEF
164
Point72 Middle East FZE
United Arab Emirates
– -$107K -18,201 Closed
Pathstone Holdings
165
Pathstone Holdings
New Jersey
– -$103K -17,599 Closed
6CM
166
683 Capital Management
New York
– -$92.3K -15,694 Closed
YIH
167
Y-Intercept (HK)
Hong Kong
– -$86K -14,618 Closed
VF
168
Virtu Financial
New York
– -$80K -13,598 Closed
DTL
169
Dynamic Technology Lab
Singapore
– -$70K -11,888 Closed
SRL
170
Scientech Research LLC
New Jersey
– -$68.6K -11,649 Closed
EGM
171
Engineers Gate Manager
New York
– -$67.4K -11,460 Closed
A
172
AJOVista
Massachusetts
– -$44.7K -7,609 Closed
SIM
173
Sandia Investment Management
Massachusetts
– -$35.2K -5,980 Closed
RTL
174
Red Tortoise LLC
Georgia
– -$2.01K -342 Closed
ODG
175
O'Dell Group
Ohio
– -$206 -35 Closed
4 5 6
7
8

COGT Hedge Fund Activity: Q1 2024 in Review

146 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2024, worth a combined $734M — up 34% from $547M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COGT positions and 30 closed out — a net gain of 3 holders — while 63 added to existing stakes and 37 trimmed.

The largest buyer was State Street, adding an estimated $21.5M. The largest seller was Suvretta Capital Management, cutting an estimated $21M.

  • 146 institutional investors held Cogent Biosciences (COGT) as of Q1 2024, up from 144 in Q4 2023.
  • Funds reported $734M of Cogent Biosciences stock for Q1 2024, up 34% quarter-over-quarter.
  • 33 funds opened new Cogent Biosciences positions in Q1 2024 and 30 closed out, a net change of +3 holders.
  • The largest Cogent Biosciences buyer in Q1 2024 was State Street, an estimated $21.5M added.
  • The largest Cogent Biosciences seller in Q1 2024 was Suvretta Capital Management, an estimated $21M sold.

Based on aggregated 13F filings for Q1 2024.